In the last years, numerous studies have confirmed the ability of A2A adenosine receptor antagonists to prevent neurodegenerative diseases such as Parkinson???s and Alzheimer???s diseases, ischemic brain damage and, recently, epilepsy and sensorimotor disorders (restless legs syndrome???RLS) [8???14].